F.D.A. Wants More Tests on a Novo Nordisk Insulin, Tresiba
The request by the F.D.A. for more data on the heart risks of a diabetes drug will delay an important product for Novo Nordisk of Denmark.
Tags:
F.D.A. Wants More Tests on a Novo Nordisk Insulin, Tresiba,
Diabetes Latest News